MY VIEW | PAUL FELL Jessica Kennedy Jun 28, 2024 Jun 28, 2024 0 Related to this story Most Popular Challenges are what make life interesting — Richard Kyte Embracing difficulty builds resilience, deepens perspective and reveals strengths that comfort and routine seldom uncover in us. What happens when fewer people choose to have children? | The Ethical Life podcast 🎧 Large households once seemed ordinary. Today they often attract curiosity. The hosts discuss evolving norms around family size and personal… Upending green card process will hinder legal paths | Dallas Morning News An abrupt shift in U.S. green card policy threatens to pointlessly complicate the lives of immigrants here legally and further erode paths to … Who’s responsible when jobs go unfilled: workers or employers? | The Ethical Life podcast 🎧 The hosts examine hiring struggles, economic forces and how changing expectations around pay, flexibility and purpose are reshaping partici… This pancreatic cancer drug is so good, it got a standing ovation | Lisa Jarvis It’s not often you see a standing ovation at a medical conference. But over the weekend, a ballroom full of cancer specialists got to their fe…
Challenges are what make life interesting — Richard Kyte Embracing difficulty builds resilience, deepens perspective and reveals strengths that comfort and routine seldom uncover in us.
What happens when fewer people choose to have children? | The Ethical Life podcast 🎧 Large households once seemed ordinary. Today they often attract curiosity. The hosts discuss evolving norms around family size and personal…
Upending green card process will hinder legal paths | Dallas Morning News An abrupt shift in U.S. green card policy threatens to pointlessly complicate the lives of immigrants here legally and further erode paths to …
Who’s responsible when jobs go unfilled: workers or employers? | The Ethical Life podcast 🎧 The hosts examine hiring struggles, economic forces and how changing expectations around pay, flexibility and purpose are reshaping partici…
This pancreatic cancer drug is so good, it got a standing ovation | Lisa Jarvis It’s not often you see a standing ovation at a medical conference. But over the weekend, a ballroom full of cancer specialists got to their fe…